Skip to main content
Caplight Logo









Cypre Inc.

Cypre Inc.

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.cypre.com/

Last Round

Seed Round

Jan 10, 2024

Total Funding Raised

$1.33M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Cypre Inc. is a biotechnology company that develops a 3D tumor modeling platform designed to improve the process of cancer drug development and precision medicine.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS

AI Layer

Application

Keywords

3D tumor modelsorganoid platformoncology drug discoverypreclinical researchhydrogel technologytumor microenvironmentTMEIND-enabling studieshigh-content imaginganimal-alternative modelsbiomarker discoveryin vitro testingdrug efficacyorgan-on-a-chip3D cell culture

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cypre Inc. Comparables

Compare Cypre Inc. with similar companies based on industry and business-model similarity.

Cypre Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Carcinotech
88%
ScreenIn3D
86%
Xilis
85%

Cypre Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Seed RoundJan 10, 2024
SeedAug 10, 2018
Convertible DebtJan 18, 2017

Cypre Inc. Investors

Notable investors and investment history

Cypre Inc. investors
InvestorRounds
Hemi VenturesSeed
Kluz VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 18, 2026

    Monthly visitors increased 49% MoM.

  • May 12, 2026

    Monthly visitors grew 1891% MoM, from 79 to 1.6K.

Cypre Inc. Filings

Explore SEC and related filing metadata, where available.

Cypre Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Cypre Inc.'s valuation, stock price, and market status.

Is Cypre Inc. a public or private company?

Cypre Inc. is a private company.

What is the current stock price of Cypre Inc.?

Cypre Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is Cypre Inc. worth (valuation)?

Valuation information for Cypre Inc. is not publicly available.

Can I buy Cypre Inc. stock?

Cypre Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Cypre Inc.'s last funding round?

Cypre Inc.'s most recent funding round was Seed Round on January 10, 2024.

Who are the main investors in Cypre Inc.?

Key investors in Cypre Inc. include MBC BioLabs, Kluz Ventures.

Will Cypre Inc. IPO soon?

No public IPO plans have been announced for Cypre Inc..

How can I track Cypre Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Cypre Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range8
Year Founded2016
Last FundingJan 10, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?